Naturally, this can have a trickle-down effect on pharma’s ability to make medicine more available and less expensive, without sacrificing margins. Optimizing for better drug design .

Insilico Medicine("Insilico"), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, has successfully delivered the second preclinical candidate compound (PCC) in ...

CAMBRIDGE, Mass., Nov 14, 2024 --- Insilico Medicine(“Insilico”), a global leading generative artificial intelligence (AI)-driven biotechnology company, will be hosting Pharma.AI Week ...

CAMBRIDGE, Mass., Dec 17, 2024 --- Insilico Medicine (“Insilico”), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, is proud to announce its ...

Virtual drug design tech firm Iktos has set up a new pact with Big Pharma Pfizer to tap its artificial intelligence for its discovery work. Pfizer will use the Paris-based company’s tech for de ...